Somerset Therapeutics LLC recalls
4 recalls filed under Somerset Therapeutics LLC. The most recent was published March 25, 2026.
-
Class II · 7 months ago
Somerset Therapeutics LLC Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL recall: Failed Impurities/Degradation Specifications - OOS impurities result observed
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were…
-
Class III · 10 months ago
Somerset Therapeutics LLC Cisatracurium Besylate Injection USP, 10 mg/5 mL* recall: Subpotent product:out of specification assay results observed during long
Subpotent product:out of specification assay results observed during long term stability testing.
-
Class III · 10 months ago
Somerset Therapeutics LLC Cisatracurium Besylate Injection USP, 200mg/20mL* recall: Subpotent product:out of specification assay results observed during long
Subpotent product:out of specification assay results observed during long term stability testing.
-
Class III · 10 months ago
Somerset Therapeutics LLC Cisatracurium Besylate Injection USP, 20 mg/10 mL* recall: Subpotent product:out of specification assay results observed during long
Subpotent product:out of specification assay results observed during long term stability testing.
About this page
Somerset Therapeutics LLC appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.